Walgreen December Sales Rise 7%; Pharma Sales Strong

Last year ended well for drugstore major Walgreen (NYSE: WAG  ) , as its key operating metrics for December reveal. Total sales for the month amounted to $7.2 billion, or 7.2% higher on a year-over-year basis. Overall front-end (i.e., non-pharmacy goods) sales also rose, by 4% across the same time frame, while pharmacy sales increased by a robust 10.2%.

Comparable-store sales rose 6.1% on a year-over-year basis, while front-end "comps" advanced by 2.5% and pharmacy sales by 9%. Comparable-store customer traffic, however, saw a decline of 1.3%. 

Last month, Walgreen posted fiscal Q1 2014 results that saw year-over-year improvements in both the top and bottom line. Net sales were $18.3 billion while attributable net profit came in at $695 million ($0.72 per diluted share). Both figures were improvements over Q1 2013's figures of $17.3 billion and $413 million ($0.43), respectively.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2785199, ~/Articles/ArticleHandler.aspx, 4/24/2014 7:04:00 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement